Immuneering (IMRX) FCF Margin (2020 - 2022)
Immuneering (IMRX) recorded quarterly FCF Margin of 2597344.18% in Q4 2022, down 8949.64% quarter-over-quarter from 28701.08% in Q3 2022, and down 259246418.0% on a YoY basis from N/an in Q4 2021.
Immuneering (IMRX) FCF Margin (2020 - 2022) Analysis & Trends
Immuneering's FCF Margin history runs 3 years deep, the most recent figure standing at 2597344.18% for Q4 2022.
- In Q4 2022, FCF Margin fell 259246418.0% year-over-year to 2597344.18%; the TTM figure through Sep 2023 stood at 10809489.45% (down 1080113559.0% YoY), while the FY2022 annual figure was 14148.44%, down 1266227.0% from the prior year.
- FCF Margin was 2597344.18% for Q4 2022 at Immuneering, down from 28701.08% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 511.54% in Q3 2020 to a low of 2597344.18% in Q4 2022.
- Historically, FCF Margin has averaged 265287.05% across 3 years, with a median of 3378.13% in 2021.
- The sharpest annual moves came in 2021 and 2022: FCF Margin sank 136471 bps in 2021, then plunged 259246418 bps in 2022.
- A 3-year view of FCF Margin shows it stood at 825.64% in 2020, then sank by 491 bps to 4880.0% in 2021, then slumped by 53124 bps to 2597344.18% in 2022.
- The last three FCF Margin figures came in at 2597344.18% (Q4 2022), 28701.08% (Q3 2022), and 10182.56% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2,597,344.18% |
| Sep 30, 2022 | -28,701.08% |
| Jun 30, 2022 | -10,182.56% |
| Mar 31, 2022 | -6,748.08% |
| Dec 31, 2021 | -4,880.00% |
| Sep 30, 2021 | -1,876.25% |
| Jun 30, 2021 | -978.31% |
| Mar 31, 2021 | -822.83% |
| Dec 31, 2020 | -825.64% |
| Sep 30, 2020 | -511.54% |